You are here

Novartis

Go or no go? Valuable drugs set for FDA decisions

EP Vantage

Wed, 07/29/20 - 10:54 am

belantamab mafodotin

Gilead Sciences

Novartis announces phase III study of Jakavi in chronic graft-versus-host disease met primary and key secondary endpoints

Pharmaceutical Business Review

Tue, 07/28/20 - 10:30 am

graft vs host disease

Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing

BioPharma Dive

Mon, 07/27/20 - 11:05 pm

drug manufacturing

Former Novartis sales rep gets $109M for blowing the whistle on doctor kickbacks

Fierce Pharma

Fri, 07/24/20 - 09:29 am

whistleblower lawsuits

Ruxolitinib passes another PhIII test for graft-versus-host disease, a win for Incyte and Novartis

Endpoints

Thu, 07/23/20 - 11:06 am

graft vs host disease

Novartis introduces inflammatory villain in its first Xiidra dry eye DTC campaign

Fierce Pharma

Thu, 07/23/20 - 10:51 am

DTC advertising

dry eye disease

Novartis dumps Ziarco eczema drug, taking $485M hit

Fierce Biotech

Tue, 07/21/20 - 10:51 am

Novartis profit slips as stockpiling reverses

Marketwatch

Tue, 07/21/20 - 10:49 am

Biogen to launch Phase IV study of spinal muscular atrophy drug in post-gene therapy patients

MedCity News

Tue, 07/21/20 - 10:37 am

clinical trials

spinal muscular atrophy

10 most valuable R&D projects in the pharmaceutical industry pipeline

Beckers Hospital Review

Mon, 07/20/20 - 11:49 pm

drug development

Bristol-Myers Squibb

Vir Biotechnolgy

Eli Lilly’s Mirikizumab Hits the Mark in Phase III Study, Bests Cosentyx

BioSpace

Sat, 07/18/20 - 12:17 pm

clinical trials

Novartis to provide 'no profit' COVID-19 drugs to low income countries

Reuters

Thu, 07/16/20 - 11:00 am

developing countries

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

Forbes

Wed, 07/15/20 - 11:22 pm

artificial intelligence

machine learning

pharma industry

drug development

Novartis' Entresto gains steam with cardiologists despite stinging heart failure trial flop

Fierce Pharma

Wed, 07/15/20 - 11:17 am

Propeller gets green light to bundle its digital health tools with inhalers

MedCity News

Thu, 07/9/20 - 11:05 am

Propeller Health

digital therapeutics

Pharma's pandemic response could help attract tech talent, Novartis digital chief says

Fierce Pharma

Tue, 07/7/20 - 08:13 pm

pharma industry

Novartis partners with Civica Rx to ease hospital shortages for 6 high-demand generic injectables

Fierce Pharma

Tue, 07/7/20 - 08:05 pm

Pfizer, Novartis and more halt July ads on Facebook to protest hate and racism

Fierce Pharma

Thu, 07/2/20 - 11:33 pm

pharma advertising

Novartis to pay $678M to settle claims over 'sham' doctor events

BioPharma Dive

Thu, 07/2/20 - 11:39 am

Amgen's Enbrel Patents to Be Upheld Through 2029

Motley Fool

Thu, 07/2/20 - 12:15 am

rheumatoid arthritis

Pages